NCT06885931View on ClinicalTrials.gov

Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)

NARecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

August 31, 2029

Conditions
Mixed Urinary IncontinenceStress Urinary Incontinence (SUI)Chronic Pelvic Pain
Interventions
DEVICE

Pudendal neuromodulation

In this feasibility study, all subjects will receive the Amber UI system.

Trial Locations (1)

655, 2650

RECRUITING

Universitair Ziekenhuis Antwerpen, Edegem

Sponsors
All Listed Sponsors
lead

Amber Therapeutics Ltd

INDUSTRY

NCT06885931 - Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications) | Biotech Hunter | Biotech Hunter